Reagents and Consumables
ID: NIH-CC-OPC-25-000159Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/103d4525d6194a6e83e9c99252ab78b7/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a Firm-Fixed price purchase order for various reagents and consumables necessary for clinical patient care testing at the NIH Clinical Center. The procurement is intended to secure proprietary products from Life Technologies Corporation, which are essential for diagnosing and monitoring hematological disorders, ensuring compliance with regulatory standards, and maintaining the integrity of laboratory operations. Interested vendors capable of providing equivalent products are invited to submit capability statements by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition will adhere to the simplified acquisition threshold and is being conducted under FAR Subpart 13.106-1(b)(i) for sole source procurement.

    Point(s) of Contact
    Kimala Winfield
    (301) 496-7015
    kimala.winfield@nih.gov
    Malinda Dehner
    (301) 594-6320
    dehnerm@cc.nih.gov
    Files
    Title
    Posted
    LIST OF SUPPLIES-25-000159.docx
    The government document outlines a list of supplies required for laboratory operations associated with the 3500 series equipment. It specifies various reagents, containers, and assay kits essential for conducting experiments. Items listed include 28 units of "Conditioning Reagent 3500 Series," 10 units of "TAQMAN UNIV MMIX," and multiple types of PCR supermixes and assay kits with specified quantities. The detailed descriptions include item numbers and the quantity needed for each type. This document likely serves as part of a broader government RFP or federal grant application aimed at ensuring laboratories have the necessary supplies to conduct research effectively and comply with scientific standards. The structure presents a straight list format, showcasing the government's systematic approach to procurement in support of scientific initiatives.
    Lifecycle
    Title
    Type
    Reagents and Consumables
    Currently viewing
    Presolicitation
    Similar Opportunities
    Werfen USA LLC Various Consumables and lease of two ACL Top 750 Instruments for the Department of Laboratory Medicine at the NIH Clinical Center
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a firm fixed price purchase order to Werfen USA LLC for various consumables and the lease of two ACL Top 750 instruments for the Department of Laboratory Medicine at the NIH Clinical Center. This acquisition aims to extend the lease of the ACL TOP 750 analyzers, which are critical for conducting routine and specialized coagulation tests in mid to high-volume clinical laboratories, enhancing lab efficiency and result reliability. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by December 27, 2024, 6:30 AM EST, with the total contract value not exceeding $250,000, as this procurement is being conducted under Simplified Acquisition Procedures.
    In Vitro Biological Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source procurement with Becton, Dickinson and Company for various in vitro biological reagents essential for research purposes. The procurement includes specific quantities of antibodies and reagents, such as Hu CD183 BV711 and Hu IL-13 BV421, along with shipping and handling to be delivered to Gaithersburg, Maryland. This procurement is justified under the authority of 41 U.S.C. 1901 (a)(1), indicating that only one responsible source can meet the agency's requirements. Interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024, with all submissions considered at the Government's discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    cDNA-PCR Sequencing Kits for long-read sequencing.
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of cDNA-PCR Sequencing Kits for long-read sequencing, as part of a combined synopsis/solicitation. The primary objective is to acquire Promethion Flow Cell packs and sequencing kits to support high-throughput sequencing efforts aimed at advancing research on neurodegenerative diseases, particularly Alzheimer's disease. This procurement is crucial for the Center for Alzheimer’s Disease and Related Dementias (CARD) and is expected to facilitate the identification of causative genes and potential therapeutic targets. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on December 30, 2024, referencing Solicitation Number 75N95025Q00008, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    Long Sequencing Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) NIDA, is seeking qualified small businesses to provide Long Sequencing Kits as part of a Sources Sought notice. The primary objective of this procurement is to acquire kits that facilitate long read sequencing for analyzing biomarkers related to Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD), which are crucial for understanding disease progression and therapeutic efficacy. The kits must meet specific technical requirements, including compatibility with Nanopore PromethION 48 sequencers and the ability to generate substantial sequencing data in real-time. Interested parties must submit their capability statements to Andrea Clay at amcgee@nida.nih.gov by December 31, 2024, at 12:00 PM Eastern Time, as this notice is strictly for research and information purposes and does not obligate the government to award a contract.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for biomarkers abeta42, abeta40, and pTau 217, which will be utilized in research involving stored samples from the Baltimore Longitudinal Study of Aging (BLSA) to assess cognitive decline and neurodegeneration. This procurement is critical for advancing Alzheimer’s research and will be awarded as a firm fixed-price purchase order, with quotations due by 5:00 p.m. Eastern Time on January 8, 2025. Interested vendors should contact Iris Merscher at iris.merscher@nih.gov for further details.
    Brand Name Biological Product
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a brand name biological product under solicitation number RFQ-NIAID-25-2251721. The procurement involves the acquisition of specific biological supplies, including various anti-human antibodies, to support the National Institute of Allergy and Infectious Diseases (NIAID) in its research efforts. These products are critical for advancing biomedical research and ensuring the availability of high-quality reagents for scientific studies. Interested vendors must submit their offers by December 22, 2024, at 10:00 AM EST, and can direct inquiries to Calvin Robinson at calvin.robinson@nih.gov.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    Notice of Intent to Sole Source – TheraDoc subscription
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.